Versant Venture Capital III, L.P.

Filings by Versant Venture Capital III, L.P. span 4 companies, the busiest being Flexion Therapeutics Inc, Immune Design Corp. and Ocular Therapeutix, Inc. Over a trading history stretching from 6 August 2010 to 15 June 2015, the count stands at 24 filings.

Both buying and selling appear: 4 purchases worth €8.5M, against 5 sales worth €16.4M. Taken together, the sales exceed the purchases by €7.9M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 2 share grants. So far in 2015, the count stands at no purchases and 4 sales.

In size, the median ticket on the buying side is €2.5M.

The record was last updated on 15 June 2015 with an open-market sale (€6.2M) in Ocular Therapeutix, Inc. The last insider purchase was made public on 31 July 2014, 4,484 days ago. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.